Related Experiment Video
Updated: Dec 2, 2025
09:19
In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time
Published on: May 24, 2020
9.5K
Hyperthrombotic Milieu in COVID-19 Patients.
Mohamed Hassan Kamel1, Wenqing Yin1, Chris Zavaro1
1Renal Section, Department of Medicine, Boston University School of Medicine, Boston, MA 02118, USA.
Cells
|November 4, 2020
Summary
COVID-19 infection increases the risk of blood clots in both large and small vessels, driven by endothelial damage. Understanding these thrombosis mechanisms is crucial for developing better treatments and risk markers.
Area of Science:
- Cardiovascular Medicine
- Hematology
- Infectious Diseases
Background:
- COVID-19 (SARS-CoV-2) infection presents with diverse systemic effects.
- Increased risk of macro- and microvascular thrombosis is a recognized complication.
- Endothelial damage and dysregulated coagulation are implicated in COVID-19 pathophysiology.
Purpose of the Study:
- To review the alterations in thrombosis components in COVID-19 patients.
- To highlight the role of the extrinsic coagulation cascade and endotheliopathy.
- To discuss breakthrough thrombosis and anticoagulation therapy.
Main Methods:
- Literature review of COVID-19-related coagulopathy.
- Analysis of mechanisms driving macro- and microvascular thrombosis.
- Examination of clinical nuances and therapeutic strategies.
Main Results:
- COVID-19 is associated with significant risks of arterial and venous thrombosis (stroke, ACS, VTE).
- Microvascular thrombosis contributes to multisystem organ failure.
- Endothelial cell damage (endotheliopathy) is a primary driver of thrombosis, activating the extrinsic coagulation cascade.
Conclusions:
- Endotheliopathy and extrinsic pathway activation are central to COVID-19 coagulopathy.
- Further research into COVID-19-specific thrombosis mechanisms is needed.
- Development of targeted therapies and improved risk markers is essential.
Related Concept Videos
01:30Venous Thrombosis I: Introduction
143
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
143
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
1.3K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.3K
01:29Venous Thrombosis III: Interprofessional Care
155
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
155
01:20Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
153
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
153
01:24Disorders of Hemostasis
1.6K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
1.6K
01:29Pulmonary Embolism I: Introduction
305
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
305